IMC Response to PMPRB Interim Approach Consultation
IMC’s members continue to have significant concerns regarding changes to the PMPRB and future Guidelines that will implement the revised schedule of international reference countries.
Transforming Canadians’ lives
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
BENEFITS OF INNOVATIVE MEDICINES
Real hope for patients and families
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Transformation
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Safety
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Sustainability
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Industry impact In Canada
Better Health Outcomes
48
Innovative Medicines Canada members
100,000
High-quality jobs
$15 billion
Yearly economic impact
LATEST RESOURCES
Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response
IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption.
Search for Specific Brand Name Drug Negotiations Status with the pCPA
Use this tool to search for brand name drugs to view their current negotiation status.
pCPA overview of the Negotiation Process
Learn more about the negotiation process from the pCPA.
Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing
This policy note characterizes Canada’s current testing infrastructure and its limitations, which include that it hinders current and future patient access to the best available treatments.
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022
2022 Code of Ethical Practices
Our Code of Ethical Practices guides the activities of all our members’ employees as they interact with stakeholders to commercialize prescription medicines (excluding medical devices and over-the-counter products). Adherence to the Code is a condition of membership.
LATEST PRESS RELEASES
Press Release July 06, 2022
Innovative Medicines Canada Acknowledges the Amendments to the Patented Medicines Regulations Published in The Canada Gazette, Part II
Ottawa, July 6, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, acknowledges the amendments to […]
Press Release June 17, 2022
WTO Decision on Waiving Intellectual Property Rights is the Wrong Solution to Address Barriers to Vaccine Equity
Ottawa, June 17, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, is disappointed by the intellectual […]
Press Release June 15, 2022
Concerns Remain with How Regulatory Changes Could Impact Patient Access to New Medicines
Ottawa, June 15, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, acknowledges the release of the […]
Press Release June 10, 2022
Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)
Ottawa, June 9, 2022 – The associations representing the global research-based biopharmaceutical industry reaffirm that weakening the intellectual property (IP) framework […]
Press Release June 06, 2022
Innovative Medicines Canada Welcomes Quebec’s Rare Disease Strategy
Ottawa, June 6, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, applauds the Quebec government on […]
Press Release May 30, 2022
Innovative Medicines Canada welcomes new Board Chair, Alok Kanti
Ottawa, May 30, 2022 – Innovative Medicines Canada (IMC) is pleased to announce Alok Kanti, President and Chief Executive Officer of […]
Press Release May 25, 2022
Health Research Foundation Now Accepting Nominations for its Medal of Honour
Nominate a remarkable individual who is making a difference in health sciences by June 22. OTTAWA, ON, May 25, 2022 […]
Press Release May 12, 2022
Innovative Medicines Canada applauds Quebec’s new Life Sciences Strategy
Ottawa, May 12, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, welcomes Quebec’s new Life […]